Lastest News from SidaLuk:
NYC Emerging Technologies Summit was great opportunity to talk to fellow entrepreneurs, venture capitalists and tech consultants. It is nice to step out of the lab and share our findings with people invested in life sciences.
For more news, follow us on Facebook
About Our Research:
SiDaLuk is developing a new diagnostic assay for automated diagnosis of prostate cancer. Prostate cancer is the most common cancer among American men and second leading cause of cancer-related death. About 23 million men are screen for prostate cancer annually with about 250,000 being diagnosed with the cancer. (learn more)